{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:08:27Z","timestamp":1782947307313,"version":"3.54.5"},"reference-count":24,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,9,27]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:p>A 70-year-old man was referred to our respiratory department with non-productive cough over the past 6 months. High-resolution CT revealed reticular pattern with basal and peripheral predominance, centrilobular nodules and mild ground glass opacities. Serology tests were normal and bronchoalveolar lavage revealed lymphocytosis. Pulmonary function tests showed functional impairment and reduced diffusing capacity for carbon monoxide. Meticulous evaluation of patient\u2019s medical history unveiled longitudinal administration of infliximab due to diagnosis of psoriasis. The working diagnosis of drug-induced interstitial lung disease was proposed following multidisciplinary discussion. Considerable radiological and functional improvement was determined 6 months following infliximab discontinuation without implementation of corticosteroids. To this end, the patient has reported remission of cough and functional improvement.<\/jats:p>","DOI":"10.1136\/bcr-2021-245726","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T13:57:53Z","timestamp":1634133473000},"page":"e245726","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Infliximab-induced interstitial lung disease"],"prefix":"10.1136","volume":"14","author":[{"given":"Theodoros","family":"Karampitsakos","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania","family":"Papaioannou","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Sampsonas","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyrios","family":"Tzouvelekis","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, University Hospital of Patras, Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,10,13]]},"reference":[{"key":"2025082800553166000_14.10.e245726.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201506-1063ST"},{"key":"2025082800553166000_14.10.e245726.2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST"},{"key":"2025082800553166000_14.10.e245726.3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112297","article-title":"Old and new biological therapies for psoriasis","volume":"18","author":"R\u00f8nholt","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2025082800553166000_14.10.e245726.4","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2019.00041","article-title":"Biologic treatments in interstitial lung diseases","volume":"6","author":"Karampitsakos","year":"2019","journal-title":"Front Med"},{"key":"2025082800553166000_14.10.e245726.5","first-page":"579","article-title":"Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database","volume":"35","author":"Sfikakis","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2025082800553166000_14.10.e245726.6","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3283483ea5"},{"key":"2025082800553166000_14.10.e245726.7","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746080-00002"},{"key":"2025082800553166000_14.10.e245726.8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-2600(15)00199-X","article-title":"New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches","volume":"3","author":"Baughman","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2025082800553166000_14.10.e245726.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200603-402OC"},{"key":"2025082800553166000_14.10.e245726.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.11.002"},{"key":"2025082800553166000_14.10.e245726.11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2006.02.010","article-title":"Infliximab-induced non-specific interstitial pneumonia and lupus-like eruption","volume":"17","author":"Pataka","year":"2006","journal-title":"Eur J Intern Med"},{"key":"2025082800553166000_14.10.e245726.12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/ced.14259","article-title":"The risk of interstitial lung disease during biological treatment in Japanese patients with psoriasis","volume":"45","author":"Matsumoto","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"2025082800553166000_14.10.e245726.13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/14712598.2017.1287169","article-title":"Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies","volume":"17","author":"Chen","year":"2017","journal-title":"Expert Opin Biol Ther"},{"key":"2025082800553166000_14.10.e245726.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2014.12.004"},{"key":"2025082800553166000_14.10.e245726.15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket175"},{"key":"2025082800553166000_14.10.e245726.16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1586\/1744666X.2013.811173","article-title":"Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis","volume":"9","author":"Atzeni","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"2025082800553166000_14.10.e245726.17","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090030"},{"key":"2025082800553166000_14.10.e245726.18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.5.1858"},{"key":"2025082800553166000_14.10.e245726.19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.hrtlng.2013.07.005","article-title":"Respiratory failure due to infliximab induced interstitial lung disease","volume":"42","author":"Kakavas","year":"2013","journal-title":"Heart Lung"},{"key":"2025082800553166000_14.10.e245726.20","first-page":"238","article-title":"Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy","volume":"34","author":"Roos","year":"2007","journal-title":"J Rheumatol"},{"key":"2025082800553166000_14.10.e245726.21","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31824c07e8"},{"key":"2025082800553166000_14.10.e245726.22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"2025082800553166000_14.10.e245726.23","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000187"},{"key":"2025082800553166000_14.10.e245726.24","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2174\/1568026616666150930120959","article-title":"Biomarkers in the evaluation and management of idiopathic pulmonary fibrosis","volume":"16","author":"Tzouvelekis","year":"2016","journal-title":"Curr Top Med Chem"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-245726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:55:40Z","timestamp":1756367740000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-245726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,13]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1136\/bcr-2021-245726"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-245726","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}